author-photo

P. Gomez Pardo

Hebron University

18

Papers

83

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

Abstract PD1-02: Withdrawn

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P5-11-04: Anti-proliferative effect of oral metronomic vinorelbine (mVNB) in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): A randomized, three-arm, window-of-opportunity study

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Balixafortide (a CXCR4 antagonist) plus eribulin in HER2-negative metastatic breast cancer (MBC): A Phase I open-label trial

2018 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Open-label randomised phase III trial of vinflunine versus an alkylating agent in patients with heavily pretreated metastatic breast cancer

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (3)
199PAnti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
285PDBalixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT1-01-04: VENTANA (SOLTI-1501): Oral metronomic vinorelbine combined with endocrine therapy in luminal/HER2-negative early breast cancer: A window of opportunity trial

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
214TiPVENTANA (SOLTI-1501): Antiproliferative effect of the addition of oral metronomic vinorelbine to endocrine therapy in luminal/HER2-negative early breast cancer: A window of opportunity trial

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
218PPrognostic estimates of Ki-67 percentage drop after neoadjuvant chemotherapy (NAC) in luminal B (lumB) and triple negative breast cancer (TNBC)

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study

2016 The Breast
Show All
- Source
- Cite
- Save
Citations (74)